Cancer Weekly articles from July 2000

Cancer Weekly archives from July 2000

Metastasis Can Result When Growth Factor Expression is High.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- More evidence that metastasis is associated with a high expression of vascular epithelial growth factor (VEGF) by malignant prostate cells has been demonstrated by investigators at the University of Liverpool...

Specialists More Likely to Recommend their Own Therapies.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- A survey of urologists and radiation oncologists finds that each of these specialists overwhelmingly recommend their own treatment for localized prostate cancer, according to an article in the June 28th issue...

Study Results Demonstrate Brachytherapy as Effective as Surgery.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Dr. Haakon Ragde, prostate cancer specialist, presented results of a 12-year study that demonstrates brachytherapy, or implanting of radioactive seeds into the diseased prostate, is as effective as removing...

Alcohol Dramatically Increases Risk of Gene Mutation in Smokers with Lung Cancer.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Drinking alcohol dramatically boosts the risk of a common gene mutation in smokers developing lung cancer, according to researchers at the Medical College of Wisconsin and The Johns Hopkins School of Medicine....

Marijuana Ingredient Promotes Tumor Growth, Impairs Anti-Tumor Defenses.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Researchers report in the July 2000 issue of the Journal of Immunology that tetrahydrocannabinol (THC), the major psychoactive component of marijuana, can promote tumor growth by impairing the body's...

Protease Pretreatment Improves Gene Transduction.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Protease treatment prior to adenovirus-mediated gene transfer enhances transduction levels, researchers say. "The development of effective viral-mediated gene therapy for cancer requires the development of...

Many Factors Influence Success of Antibody-Based Immunotherapy.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Two factors are extremely important for determining the potential efficacy of antibody-based cancer immunotherapy, according to AltraRex Corp. researchers: * The xenotypic nature of the antibody...

Allogeneic Tumor Cell Vaccine Attacks Colon Carcinoma.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- A CD80 gene modified allogeneic colon cancer vaccine has been developed by collaborating academic and industry researchers. "We developed a practical allogeneic tumor cell vaccine for the immuno-gene...

First-of-its-Kind System Helps Diagnose Cancer.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- A new medical imaging technology unveiled by GE Medical Systems helps doctors make thorough and potentially life-saving diagnoses of cancers and other diseases in a single exam in less than half the time of...

Breakthroughs in Gene Therapy and Tissue Engineering Reported.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- The use of gene-transfer technology to repair salivary-gland tissue, allowing a pathway for saliva to flow, in patients undergoing radiation therapy for head and neck cancer, is possible in principle,...

Funding Awarded for Antibody Development.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Tularik Inc. (TLRK), San Francisco, California, announced that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Cancer Institute of the U.S. National Institutes of Health....

Vaccine Enters Phase I Clinical Trials.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Cantab Pharmaceuticals plc (CNTBY) (CTB), Cambridge, United Kingdom, announced the commencement of a Phase I clinical trial of TA-CIN, its novel vaccine candidate for the treatment of cervical dysplasia, an...

Brain Tumors Not Always Fatal.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- "You have a brain tumor." These are some of the scariest words a person can hear. But understanding more about brain tumors can also lead to an understanding that a brain tumor diagnosis is not an...

Collaboration Signed to Develop DNA-Based Cancer Products.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Coley Pharmaceutical Group, Wellesley, Massachusetts, and the Ludwig Institute for Cancer Research, Hilden, Germany, have established a clinical research collaboration for the development and evaluation of CpG...

Several Angiogenic Factors Influence Outcome in Nerve Cell Malignancies.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- The clinical outcome of neuroblastoma, a type of cancer most often found in children, can vary based on a number of significant factors. Medical researchers at the Children's Hospital of Philadelphia,...

Discovery of Signaling Pathway Could Lead to New Drugs.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Cancer researchers at Cornell University, Ithaca, New York, have learned how some proteins receive the marching orders that dispatch them to initiate signaling pathways and produce malignant cell...

p53 Gene Transfer Improves Chemosensitivity of Lung Cancer Cells.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Adenovirus-mediated p53 gene transfer synergistically improves chemosensitivity of non-small cell lung cancer cells, researchers in Japan report. "The infection of recombinant adenovirus expressing...

Multiple Herpes Simplex Vectors Efficiently Cotransduce Tumors.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Multiple herpes simplex virus (HSV) vectors with one gene each are more effective for immunizing tumors than is a single vector with multiple genes. "Many gene therapy strategies would be enhanced by...

Five-Year Cancer Survival Rate May be Misleading.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- The five-year survival rate - the standard measurement of a cancer treatment's success - may be misleading because people are being diagnosed earlier and therefore living longer with detected cancer before...

Chemotherapy Plus Total Marrow Radiation is Promising Treatment.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- A myeloablative regimen consisting of chemotherapy followed by total marrow irradiation (TRI) and hematopoietic stem cell transplantation (HSCT) may be an effective method for treating patients with poor-risk...

Post-treatment Hypothyroidism Affects About 15% of Patients.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- A study of patients who underwent surgery with or without radiotherapy for the treatment for advanced-stage nonthyroid head and neck cancer indicates an incidence of post-treatment hypothyroidism of about 15%....

Perioperative Blood Transfusion Increases Risk of Cancer Relapse.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Perioperative blood transfusion during curative resection of hepatocellular carcinoma increases the risk of intrahepatic recurrence, according to a study from Japan. "This study retrospectively evaluated...

Herpesvirus Sabotages Immune System with a New and Unusual Strategy.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- The virus associated with Kaposi's sarcoma sabotages the body's immune system in a novel and previously unsuspected way, University of California, San Francisco (UCSF), scientists report. When the...

Orthotopic Transplant More Effective than Resection for Hepatocellular Carcinoma Patients with Cirrhosis.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Despite some misgivings in the medical community about its use on cirrhotic patients with hepatocellular carcinoma (HCC), orthotopic liver transplant (OLT) generally leads to better outcomes than tumor...

Study Indicates Early Detection Has No Impact on Survival.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- A study of 510 consecutive lung cancer patients showed that detecting the disease at a very early stage when the lesion was small had no effect on survival, according to an article published in the June issue...

Tumor-Derived DNA Helps Assess Response to Antineoplastic Treatment.
July 4, 2000... 2000 JUL 4 - (NewsRx.com) -- Researchers in the People's Republic of China have studied the movement of Epstein-Barr virus (EBV) DNA in the plasma of 15 nasopharyngeal carcinoma (NPC) patients. A rapid decline in plasma EBV DNA...

Tumor-Specific Antibody Eradicates Brain Tumors in Mice.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- A new monoclonal antibody that targets a mutated protein found only in cancer cells can eradicate tumors in mice without the aid of additional toxic substances, Duke Comprehensive Cancer Center researchers...

Qualitative Assessment of PET Plus Tracer Images Recommended Over Quantitative Analysis.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Researchers in Finland recently conducted a study to evaluate the ability of positron emission tomography (PET) with 2-[flourine-18] flouro-2-deoxy-D-glucose (FDG) for the purposes of detecting recurrent head...

Scientists Identify Family of Natural Cancer-Fighting Proteins in Mice.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- A team led by scientists at the University of California, San Francisco (UCSF), has identified five proteins in mice that trigger the immune system to attack cancer. The research greatly increases the...

Android Body Fat Distribution and Weight are Significant Factors in Survival.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Study results, reported in the June 15, 2000, issue of Cancer, point to android body fat distribution at diagnosis and weight at age 30 as two factors that are as significant to the survival of patients with...

Patients with Abnormal Stress Hormone Levels More Likely to Die Sooner.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Women with advanced breast cancer who have abnormal daytime levels of cortisol, a hormone released in response to stress, are significantly more likely to die sooner than patients with normal levels of the...

Methioninase Gene Therapy is Synergistic with Recombinant Treatment.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Anticancer results obtained with methioninase gene therapy matched those obtained with recombinant methioninase treatment in a recent study. "Results obtained over the past 40 years have demonstrated...

Reactive CD4(+) T Cells Necessary for Protective Immunity.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Reactive CD4(+) T cells are necessary for the development of gene therapy-mediated long-term immunity against glioma, indicates a recent study. "Tumor cells genetically modified to secrete cytokines...

Quantity of Human Papillomavirus DNA a Predictor of Progression to Cancer.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Two studies published in the June 24 issue of The Lancet suggest that the detection of the amount of human papillomavirus (HPV) in cervical smears could help identify women at risk of cervical cancer. ...

Scientists Develop Class of Anti-Cancer Drugs.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Scientists from the Parker Hughes Institute, St. Paul, Minnesota, announced the development of a class of anti-cancer drugs that are effective against breast cancer and brain tumor cells. The results of...

Overexpression of the Glucose Transporter is an Indicator of Disease.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- A histopathologic study published in the June 15, 2000, issue of Cancer indicates that the presence of GLUT1 is a consistent finding in endometrial adenocarcinoma and that GLUT1 immunostaining may be...

Carcinogenesis Explored.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Dysfunctional homeostasis factors can lead to oral squamous cell carcinoma (oral cancer) and many squamous cell carcinomas of the head and neck (SCCHN), upon appropriate exposure to mutagens, according to a...

Cytometric Study Looks at DNA Ploidy and Sequence Copy Number Aberrations.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Researchers in Japan conducted a study to address the controversial topic of the association between DNA sequence copy number aberrations (DSCNAs) and DNA ploidy in head and neck squamous cell carcinomas...

Intraoperative Radiolymphoscintigraphy is a Practical Method of Screening for Occult Metastatic Disease.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Researchers in the United States have conducted a study to determine if intraoperative radiolymphoscintigraphy would be a feasible and practical method of screening for occult metastatic disease in certain...

Prognostic Factors for Patients with Malignant Peripheral Nerve Sheath Tumors Identified.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- "Malignant peripheral nerve sheath tumors of the head and neck region are uncommon and may be associated with neurofibromatosis or occur in a sporadic manner," explained researchers writing in the journal...

Treatment with Cord Blood Lowers Risk of Complications.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Use of blood from the umbilical cord reduces the incidence of a potentially life-threatening transplant complication, in the first study to directly compare such transplants with bone marrow transplants in...

Two-Drug Combination Therapy Shows Promise.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Melanoma researchers at University of California, San Diego (UCSD) have developed a new drug-combination therapy that has proven in Phase II clinical trials to be significantly better at extending patients'...

Radionuclide Bone Imaging Detects Mandibular Invasion.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Data from a recent study indicate that radionuclide bone imaging has an acceptable level of specificity and excellent sensitivity to make it useful for detecting bone invasion by oropharyngeal squamous cell...

Speech and Swallowing Can Be Impaired.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- A recent study evaluated the association between tumor burden and speech and swallowing function prior to surgery in patients who have oral or oropharyngeal cancer. L.A. Colangelo and colleagues from...

Researchers Measure Attitudes about Death among Terminally Ill Cancer Patients.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- An instrument called the "Schedule of Attitudes toward Hastened Death" (SAHD) appears to be a reliable and valid way to measure desire for death among terminally ill cancer patients, according to a study...

Integrin Antagonist Inhibits Cancer Growth.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Government researchers at the U.S. National Institutes of Health have used a novel alpha (v) integrin antagonist called SM256 to limit the growth of squamous cell carcinoma (SCC) in mice and cell cultures. ...

Bacille Calmette-Guerin Treatment Induces a Cytokine-Rich Bladder Environment.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Harvard University School of Medicine investigators recently reported their findings of a study that shows bacilli Calmette-Guerin (BCG) treatment for superficial bladder cancer induces a cytokine-rich...

Study Uncovers Alarming Increase Among Gay Men.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- The gay community is on the brink of a new epidemic, according to a study conducted by GayHealth.com co-founder Stephen E. Goldstone, MD. The study, presented at the Annual Meeting of the American Society...

Epstein-Barr Virus Infection Places HIV(+) Children at Risk for Smooth Muscle Tumors.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Lack of immunity to Epstein-Barr virus (EBV) places HIV infected children at higher risk of smooth muscle tumors, according to researchers in the United States and The Netherlands. "HIV infected children...

Is Testosterone a Cause?
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Is testosterone a cause of endometrial cancer? Surprising findings from a team of Dutch doctors and scientists have pinpointed the male hormone testosterone as a possible cause for cancer of the lining of...

Treatment with Nucleoside Analogue Followed by Hepatitis Vaccine Shifts Serologic Phenotype.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Treatment with the nucleoside analogue, L-FMAU, followed by vaccination changed hepatitis B infection status from chronic to recovering in the WHV/woodchuck model, researchers in the United States reported....

Hepatitis B Virus Protein Expression Causes Cell Death.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- A study presented at the 91(st) Annual Meeting of the American Association for Cancer Research suggests that hepatitis B virus (HBV) X protein is responsible for cell damage that leads to cellular death. ...

Positive Clinical Data Advance Drug to Phase III Clinical Trials.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Based on positive clinical data reviewed at an interim analysis of the Phase II AIN trial and investigators meeting held June 22-23, 2000, StressGen Biotechnologies Corp. (TSE) announced that it will proceed...

Clinical Trials of Unique Treatment Begins.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- United Kingdom biotech company ML Laboratories reports that its specialist gene therapy subsidiary, Cobra Therapeutics, has commenced Phase I/II clinical trials of its unique gene therapy cancer treatment...

HPV High-Risk Reflex Testing Introduced for Inconclusive Thinprep Pap Tests.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Quest Diagnostics Inc. (DGX), Teterboro, New Jersey, announced it is launching a new service to perform high-risk human papillomavirus (HPV) DNA testing for women with inconclusive results on their ThinPrep...

Technology and Probes Stemming from Human Genome Project Acquired.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- Ampersand Medical Corp. (AMPM), Chicago, Illinois, announced it has signed an exclusive worldwide licensing agreement with Invirion, a single-cell genomics company. The license includes human...

ACIS Test Measures Cancer Cells' DNA Content.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- ChromaVision Medical Systems, Inc. (CVSN), San Juan Capistrano, California, announced the release of a new ACIS test, DNA Ploidy, to assist the pathologist in measuring the DNA content within the nuclei of...

Endoscopic Procedure Reaches and Removes Skull-Base Tumors Through an Incision Between the Eyes.
July 11, 2000... 2000 JUL 11 - (NewsRx.com) -- A new surgical approach performed at Cedars-Sinai Medical Center, Los Angeles, California, is making hospital stays and recovery times shorter for patients who have tumors located along the bottom surface of...

RNA-Pulsed Dendritic Cells Induce Antitumor Immunity.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- RNA-pulsed dendritic cells (DC) induced antitumor immunity in a murine cancer model, according to a study from Japan. "DC are identified as the most effective antigen presenting cells," said T. Minami and...

New Application of Surgical Technique May Catch Metastases Earlier.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Research conducted at the St. Luke's Cancer Center in Bethlehem, Pennsylvania, has concluded that the application of the surgical technique known as sentinel lymph node biopsy (or lymphatic mapping) may make...

Anti-Cancer Gene Identified.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Immusol, Inc., San Diego, California, in collaboration with Dr. Flossie Wong-Staal of the University of California at San Diego, announced that Immusol's proprietary inverse genomics discovery process led to...

Ramoplanin Study to Prevent Infection Due to Vancomycin-Resistant Enterococcus Begins Enrollment.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- IntraBiotics Pharmaceuticals, Inc. (IBPI), Mountain View, California, said that it has begun patient enrollment for the Phase III clinical trial for Ramoplanin Oral. The trial is designed to demonstrate...

Phase II Immunotherapy Study Will Begin in Poland.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Cel-Sci Corp. (CVM), Vienna, Virginia, announced that the Polish Health Authorities have granted permission to start a Phase II clinical trial in head and neck cancer patients with Cel-Sci's immunotherapy...

First Phase of Major Genomic Research Partnership Announced.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Incyte Genomics, Inc. (INCY), Palo Alto, California, and Baylor College of Medicine, Houston, Texas, announced that they have entered into a major genomic research partnership. Scientists at Texas...

FDA Launches "Oncology Tools" Website.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- The U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) Internet Web site has expanded its capability to provide cancer-related information for consumers, patients, and health...

European Union Recommends Approval for Caelyx.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Alza Corp. (AZA), Mountain View, California, announced that the European Union's Committee for Proprietary Medicinal Products (CPMP) of the European Agency for the Evaluation of Medicinal Products (EMEA) has...

Antigens Licensed for Monoclonal Antibody Research.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- In a move to develop monoclonal antibodies directed against prostate cancer, Immunex Corporation (IMNX), Seattle, Washington, has licensed rights to cancer-derived antigens from UroCor, Inc. (UCOR), Oklahoma...

New Mechanism of Resistance Found in Cancer Cells.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Researchers at Ohio State University in Columbus have discovered an entirely new mechanism of drug resistance in cancer cells, and, possibly, a means to overcome the resistance. The study, published in...

Native Growth Factor May Cause Cancer in Ovaries.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Investigators at Washington University reported findings of a research project that suggest kit ligand (KL)/stem cell grow factor may promote cancer in ovarian surface epithelium (OSE) cells. The report...

Arcitumomab Imaging Complements Mammography in Making a Diagnosis.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Arcitumomab imaging is reported to be a safe, useful, and reliable adjunctive method for assessing the presence of or probability of primary breast carcinoma, with no documented immunogenicity, very few...

Sentinel Lymph Node Biopsy Useful Before Neoadjuvant Chemotherapy.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- University of Pennsylvania researchers recommend that the sentinel lymph node (SLN) biopsy should be used on some patients who will be undergoing neoadjuvant biopsy. They base this on the results of a...

Apoptosis-Inducing Drugs Target Over-Expressed Enzymes.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Scientists at Cell Pathways, Inc. (CLPA) and their collaborators have identified a new drug target that may play a key role in cancer cell survival. Exisulind (Aptosyn(TM)) and other compounds in the...

Molecule Targets Specific Enzyme.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- A selective molecule able to target specific enzymes that help spread cancer may stop the development of some tumors, according to research presented in the July 19 issue of the Journal of the American...

First Degree Relatives Express Growth Factor, Too.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Important findings from research efforts in Germany show that first degree relatives of patients who have gastric cancer express transforming growth factor (beta) (TGF-(beta)) in their stomach areas. This...

Vascular Endothelial Growth Factor is a Prognostic Indicator of Survival.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Yale University School of Medicine researchers have added to the body of evidence suggesting that vascular endothelial growth factor can be used as a prognostic indicator for survival in patients with oral and...

Surgery Alone as Effective as Surgery Plus Radiotherapy to Treat Advanced Disease.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Radiotherapy combined with surgery appears to be no more effective than surgery alone in improving survival rates of patients with locally advanced laryngeal carcinomas. "During the past few years,...

The Relation of Second Primary Tumors to Index Tumors.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Researchers in Italy recently conducted a study to examine the incidence, localization, and extent of second primary tumors occurring in patients with primary laryngeal carcinoma. The researchers also...

Polynucleotide Vaccine from Melanoma Antigen Under Development.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Researchers in the United States are developing a polynucleotide vaccine from melanoma antigens, which recognize MART-1, for evaluation in clinical trials. "MART-1, a melanoma antigen recognized by T...

Potential New Cancer Gene Identified.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- A Johns Hopkins University research team has discovered a new family of genes that contributes to the process of malignancy, shedding new light on the abnormalities that give rise to the aggressive childhood...

Combined Treatments Best for Locally Advanced Oropharyngeal Tumors.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Radiotherapy plus surgery is recommended by otolaryngologists in Italy as the best treatment for locally advanced oropharyngeal cancer. Their findings were published recently in the Journal of Surgical...

Findings Indicate that Prostate Brachytherapy Provides Long-Term Disease Control.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- According to a study published in the July 1, 2000, issue of Cancer, prostate brachytherapy provides excellent long-term disease control in patients with prostate carcinoma. The findings demonstrated very...

Study Shows Radiation Therapy Helps Patients Live Longer.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- Doctors have suspected that radiation therapy helped prevent patients from dying of prostate cancer, but had little scientific proof. Now, Richard Valicenti, MD, assistant professor of radiation oncology...

Providing Nitrous Oxide Lessens Discomfort, May Result in Increased Screenings.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- A recent study showed that patients who undergo flexible sigmoidoscopy and are given a mix of nitrous oxide and oxygen instead of oxygen alone are less likely to report discomfort during the procedure and...

Global System Promotes Exchange of Diagnostic Information.
July 25, 2000... 2000 JUL 25 - (NewsRx.com) -- According to a study featured in the July 1, 2000, issue of Cancer, a Telepathology Consultation Center (TPCC) established by the International Union Against Cancer (UICC) for the facilitation of...